Actions of N-arachidonyl-glycine in a rat neuropathic pain model
- 1 January 2008
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 54 (1), 189-193
- https://doi.org/10.1016/j.neuropharm.2007.05.004
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Potential anti-inflammatory actions of the elmiric (lipoamino) acidsBioorganic & Medicinal Chemistry, 2007
- CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanismsEuropean Journal of Neuroscience, 2006
- Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: effects of picrotoxin and strychnine on expression of Fos-like immunoreactivityPain, 2004
- 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2Receptor Partial Agonist with Antihyperalgesic and Antiallodynic EffectsJournal of Pharmacology and Experimental Therapeutics, 2004
- A structure–activity relationship study on N-arachidonoyl-amino acids as possible endogenous inhibitors of fatty acid amide hydrolaseBiochemical and Biophysical Research Communications, 2004
- Regulation of anandamide tissue levels by N-arachidonylglycineBiochemical Pharmacology, 2002
- The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic painBritish Journal of Pharmacology, 2001
- The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic painPain, 2001
- The Cannabinoid AcidsPharmacology & Therapeutics, 1999
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994